Leadership BiosJames Kublin, MD
Executive Director of Core
Dr. James Kublin is currently Executive Director of Core based at Fred Hutchinson Cancer Research Center, and a faculty member in the Global Health Program at the University of Washington. Dr. Kublin is also the founder and Director of the Center for Collaborative Research, which supports collaborative global health research endeavors by providing scientific and biomedical research expertise, project management services, and collaborative technology solutions. The Gates Foundation recently awarded Dr. Kublin a Grand Challenges Exploration award to apply high-throughput system analyses to malaria vaccine development.
Dr. Kublin was responsible for coordinating global operations across the prevention and therapeutic HIV clinical trials networks sponsored by NIH, as well as alliance management for the Collaboration for HIV Vaccine Discovery funded by the Gates Foundation. Dr. Kublin was a faculty member of the Department of International Health at Johns Hopkins University and the Center for Vaccine Development at the University of Maryland. Before moving to Seattle, Jim was Director, HIV Vaccines – Infectious Diseases, for Merck & Co., Inc where he played a key role in the development and implementation of HIV vaccine studies, overseeing the coordination of clinical assays, site identification and development, government and ethical approvals and providing guidance on vaccine policy issues.
Jim has a long history in international healthcare having worked with disadvantaged and refugee populations in South and Central America, Southeast Asia and Africa. His interests recently took him to Malawi where he established several study-sites evaluating anti-malarials and the interactions between HIV and malaria. He was a faculty member at the University of Malawi, College of Medicine, and provided training throughout Africa on epidemiology, malaria, and HIV.
Jim completed his B.S. and M.D. at Georgetown University, where he also conducted research on malaria. He received an M.P.H. and completed a residency in Preventive Medicine at Johns Hopkins University. Jim continued work in vaccine development and the molecular epidemiology of drug resistance to malaria while attending the University of Maryland's School of Medicine for his fellowship in Vaccinology at the Center for Vaccine Development.